PMR on the podium @profbdasgupta, with a positive phase 3! Sarilumab in relapsing PMR (SAPHYR): sari q2w+14w taper vs placebo+52w taper underrecruited 118/280 (COVID) but still hit primary, almost all secondary Better outcome + steroid-sparing: big LB0006 #EULAR2022 @RheumNow https://t.co/nd3TSibYa0